奥拉西坦联合丹红注射液治疗老年脑梗死临床疗效观察

Clinical Observation of Olazacam and Danhong Injection in Treatment of Senile Cerebral Infarction

目的探讨对老年脑梗死患者采用奥拉西坦联合丹红进行治疗的临床疗效。方法选取我院在2015年1月—2017年1月收治的70例老年脑梗死患者,并随机分为两组,对照组的35例患者单独采用奥拉西坦进行治疗,观察组的35例患者在此基础上加用丹红注射液进行治疗。结果治疗前,两组患者的神经功能缺损程度差异无统计学意义(P>0.05);治疗后,观察组患者的神经功能缺损程度低于对照组(P<0.05);观察组患者的治疗有效率优于对照组(P<0.05)。结论对老年脑梗死患者采用奥拉西坦联合丹红注射液进行治疗,能够改善患者的神经功能缺损程度,临床治疗效果较好。

Objective To explore the clinical efficacy of olaquetan combined with Danhong Injection in treatment of elderly patients with cerebral infarction. Methods 70 patients with senile cerebral infarction admitted in our hospital from January 2015 to January 2017 were randomly divided into two groups, the control group of 35 patients were treated with oxiracetam alone, in the observation group, 35 patients were treated with Danhong Injection. Results There was no significant difference in neurological deficits between the two groups before treatment （P 〉 0.05）. After treatment, the neurological deficit of the observation group was significantly lower than that of the control group （P 〈 0.05）. The effective rate of treatment in the observation group was significantly better than that in the control group （P 〈 0.05）. Conclusion Oxiracetam combined with Danhong Injection for treatment of senile cerebral infarction patients, can significantly improve the degree of neurological deficits in patients with clinical treatment is better.